1037597-73-1

Basic information

• Product Name: 2,4-Diiodooxazole
• Synonyms: 2,4-Diiodooxazole;2,4-Diiodooxazole 97%;2,4-diiodo-1,3-oxazole
• CAS NO: 1037597-73-1
• Molecular Formula: C₃HI₂NO
• Molecular Weight: 320.85508
• Product Categories: Building Blocks;Chemical Synthesis;Halogenated Heterocycles;Heterocyclic Building Blocks;Oxazoles
• Mol File: 1037597-73-1.mol
• Article Data: 1

Chemical Properties

• Melting Point: 98-103℃
• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2,4-Diiodooxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Diiodooxazole(1037597-73-1)
• EPA Substance Registry System: 2,4-Diiodooxazole(1037597-73-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 1037597-73-1(Hazardous Substances Data)

Usage

General Description

2,4-Diiodooxazole is a chemical compound with the molecular formula C2H2I2N2O. It is a member of the oxazole family, which is known for its role in medicinal chemistry and drug development. 2,4-Diiodooxazole has been studied for its potential antimicrobial and anticancer properties. It is also used as a building block in the synthesis of more complex organic compounds. The compound's structure and reactivity make it a valuable tool for researchers in the fields of organic chemistry and pharmaceutical science.

Upstream product

• 288-42-6 oxazol 

Downstream Products

• 838-41-5 2,4-diphenyl-1,3-oxazole 
• 1210372-47-6 2-iodo-4-phenyl-1,3-oxazole 
• 1210372-46-5 4-iodo-2-phenyl-1,3-oxazole 
• 1224742-18-0 4-iodooxazole 
• 1210372-52-3 1-[3-(2-iodo-1,3-oxazol-4-yl)phenyl]ethanone 
• 1210372-54-5 4-(3,5-difluorophenyl)-2-iodooxazole 
• 1210372-48-7 2-(3-fluorophenyl)-4-iodo-1,3-oxazole 
• 1210372-49-8 4-(3-fluorophenyl)-2-iodo-1,3-oxazole 
• 1210372-50-1 4-iodo-2-(4-methoxyphenyl)oxazole 
• 1210372-51-2 2-iodo-4-(4-methoxyphenyl)oxazole 
• 1403356-16-0 2,4-bis(4-methoxyphenyl)oxazole 

Relevant articles and documents

FACTOR IXA INHIBITORS

The present invention provides a compound of Formula (I) (structurally represented) wherein R1 is H or C1-6 alkyl, R2 is H or C1-6 alkyl or CH20H, R3 is H or C1-6 alkyl, and R4 is H or C1-6 alkyl, provided that when R1, R2, and R3 are H, R4 is C1-6 alkyl, and when R1, R2, and R4 are H, then R3 is C1-6 alkyl, and when R1, R3, and R4 are H, R2 is C1-6 alkyl or-CH20H, and when R2, R3, and R4 are H, then R1 is C 1-6 alkyl; A is 1 ) a 9-10 membered bicyclic heterocycle having 1-3 heteroatoms independently selected from N, S and 0, which 9-10 membered bicyclic heterocycle is unsubstituted or substituted with R5 and unsubstituted or substituted with R6 and unsubstituted or substituted with NH2, or 2) a 6-9 membered monocyclic or bicyclic carbocyclic ring system unsubstituted or substituted with R5, unsubstituted or substituted with R6, and unsubstituted or substituted with -CH2NH2; and B is 1) a 5- or 6-membered monocyclic heterocycle having 1 or 2 heteroatoms independently selected from N, S or 0, which is unsubstituted or substituted on a carbon or nitrogen atom with R7, unsubstituted or substituted on a carbon or nitrogen atom with R8, and unsubstituted or substituted on a carbon or nitrogen atom with R9, or 2) an 8- or 9-membered fused bicyclic heterocycle having 1, 2 or 3 nitrogen atoms which is unsubstituted or substituted on a carbon or nitrogen atom with R7, and unsubstituted or substituted on a carbon or nitrogen atom with R8; and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses.